267 related articles for article (PubMed ID: 6906229)
1. The binding of human complement component C4 to antibody-antigen aggregates.
Campbell RD; Dodds AW; Porter RR
Biochem J; 1980 Jul; 189(1):67-80. PubMed ID: 6906229
[TBL] [Abstract][Full Text] [Related]
2. Formation of covalent complexes between the fourth component of human complement and IgG immune aggregates.
Alcolea JM; Antón LC; Marqués G; Sánchez-Corral P; Vivanco F
Complement; 1987; 4(1):21-32. PubMed ID: 3568629
[TBL] [Abstract][Full Text] [Related]
3. Binding of human C4 to C-reactive protein-pneumococcal C-polysaccharide complexes during activation of the classical complement pathway.
Volanakis JE; Narkates AJ
Mol Immunol; 1983 Nov; 20(11):1201-7. PubMed ID: 6558418
[TBL] [Abstract][Full Text] [Related]
4. The binding of complement component C3 to antibody-antigen aggregates after activation of the alternative pathway in human serum.
Gadd KJ; Reid KB
Biochem J; 1981 May; 195(2):471-80. PubMed ID: 7316962
[TBL] [Abstract][Full Text] [Related]
5. Covalent association of C3b with C4b within C5 convertase of the classical complement pathway.
Takata Y; Kinoshita T; Kozono H; Takeda J; Tanaka E; Hong K; Inoue K
J Exp Med; 1987 Jun; 165(6):1494-507. PubMed ID: 3495629
[TBL] [Abstract][Full Text] [Related]
6. A covalent dimer of complement C4b serves as a subunit of a novel C5 convertase that involves no C3 derivatives.
Masaki T; Matsumoto M; Yasuda R; Levine RP; Kitamura H; Seya T
J Immunol; 1991 Aug; 147(3):927-32. PubMed ID: 1861081
[TBL] [Abstract][Full Text] [Related]
7. The assembly of early components of complement on antibody-antigen aggregates and on antibody-coated erythrocytes.
Goers JW; Porter RR
Biochem J; 1978 Nov; 175(2):675-84. PubMed ID: 743217
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of action of the C4 nephritic factor. Deregulation of the classical pathway of C3 convertase.
Gigli I; Sorvillo J; Mecarelli-Halbwachs L; Leibowitch J
J Exp Med; 1981 Jul; 154(1):1-12. PubMed ID: 7019379
[TBL] [Abstract][Full Text] [Related]
9. A single arginine to tryptophan interchange at beta-chain residue 458 of human complement component C4 accounts for the defect in classical pathway C5 convertase activity of allotype C4A6. Implications for the location of a C5 binding site in C4.
Ebanks RO; Jaikaran AS; Carroll MC; Anderson MJ; Campbell RD; Isenman DE
J Immunol; 1992 May; 148(9):2803-11. PubMed ID: 1573269
[TBL] [Abstract][Full Text] [Related]
10. Modulation of the classical pathway C3 convertase by plasma proteins C4 binding protein and C3b inactivator.
Gigli I; Fujita T; Nussenzweig V
Proc Natl Acad Sci U S A; 1979 Dec; 76(12):6596-600. PubMed ID: 293746
[TBL] [Abstract][Full Text] [Related]
11. Two clusters of acidic amino acids near the NH2 terminus of complement component C4 alpha'-chain are important for C2 binding.
Pan Q; Ebanks RO; Isenman DE
J Immunol; 2000 Sep; 165(5):2518-27. PubMed ID: 10946278
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of immune precipitation by complement.
Hong K; Takata Y; Sayama K; Kozono H; Takeda J; Nakano Y; Kinoshita T; Inoue K
J Immunol; 1984 Sep; 133(3):1464-70. PubMed ID: 6747294
[TBL] [Abstract][Full Text] [Related]
13. The fluid-phase binding of human C4 and its genetic variants, C4A3 and C4B1, to immunoglobulins.
Kishore N; Shah D; Skanes VM; Levine RP
Mol Immunol; 1988 Sep; 25(9):811-9. PubMed ID: 3264881
[TBL] [Abstract][Full Text] [Related]
14. A study of a covalent-like interaction between soluble nascent C4b and C4-binding protein.
Villiers MB; Thielens NM; Reboul A; Colomb MG
Biochim Biophys Acta; 1982 Jun; 704(2):197-203. PubMed ID: 6980671
[TBL] [Abstract][Full Text] [Related]
15. The low C5 convertase activity of the C4A6 allotype of human complement component C4.
Kinoshita T; Dodds AW; Law SK; Inoue K
Biochem J; 1989 Aug; 261(3):743-8. PubMed ID: 2803239
[TBL] [Abstract][Full Text] [Related]
16. Interaction of C4-binding protein with cell-bound C4b. A quantitative analysis of binding and the role of C4-binding protein in proteolysis of cell-bound C4b.
Fujita T; Tamura N
J Exp Med; 1983 Apr; 157(4):1239-51. PubMed ID: 6601177
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of activation of the classical pathway of complement by monoclonal IgE (DES). Restricted regulation of C4b by C4b-binding protein.
Saint-Remy JM
Eur J Immunol; 1984 Mar; 14(3):254-9. PubMed ID: 6608450
[TBL] [Abstract][Full Text] [Related]
18. The molecular basis for the difference in immune hemolysis activity of the Chido and Rodgers isotypes of human complement component C4.
Isenman DE; Young JR
J Immunol; 1984 Jun; 132(6):3019-27. PubMed ID: 6609966
[TBL] [Abstract][Full Text] [Related]
19. C1- inactivator: its efficiency as a regulator of classical complement pathway activation by soluble IgG aggregates.
Doekes G; van Es LA; Daha MR
Immunology; 1983 Jun; 49(2):215-22. PubMed ID: 6852866
[TBL] [Abstract][Full Text] [Related]
20. Formation of covalently linked C3-C3 dimers on IgG immune aggregates.
Barrio E; Antón LC; Marqués G; Sánchez A; Vivanco F
Eur J Immunol; 1991 Feb; 21(2):343-9. PubMed ID: 1999223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
